JP2023523096A5 - - Google Patents
Info
- Publication number
- JP2023523096A5 JP2023523096A5 JP2023506362A JP2023506362A JP2023523096A5 JP 2023523096 A5 JP2023523096 A5 JP 2023523096A5 JP 2023506362 A JP2023506362 A JP 2023506362A JP 2023506362 A JP2023506362 A JP 2023506362A JP 2023523096 A5 JP2023523096 A5 JP 2023523096A5
- Authority
- JP
- Japan
- Prior art keywords
- amino acid
- approximately
- acid sequence
- sequence seq
- containing amino
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
Applications Claiming Priority (7)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US202063012783P | 2020-04-20 | 2020-04-20 | |
| US202063012786P | 2020-04-20 | 2020-04-20 | |
| US63/012,783 | 2020-04-20 | ||
| US63/012,786 | 2020-04-20 | ||
| US202063081662P | 2020-09-22 | 2020-09-22 | |
| US63/081,662 | 2020-09-22 | ||
| PCT/CA2021/050544 WO2021212222A1 (en) | 2020-04-20 | 2021-04-20 | Compositions and methods for treatment of acute respiratory distress syndrome |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| JP2023523096A JP2023523096A (ja) | 2023-06-01 |
| JP2023523096A5 true JP2023523096A5 (cg-RX-API-DMAC10.html) | 2024-04-25 |
Family
ID=78270861
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2023506362A Pending JP2023523096A (ja) | 2020-04-20 | 2021-04-20 | 急性呼吸促迫症候群を治療するための組成物および方法 |
Country Status (8)
| Country | Link |
|---|---|
| US (1) | US20230192881A1 (cg-RX-API-DMAC10.html) |
| EP (1) | EP4138912A4 (cg-RX-API-DMAC10.html) |
| JP (1) | JP2023523096A (cg-RX-API-DMAC10.html) |
| CN (1) | CN115697410A (cg-RX-API-DMAC10.html) |
| AU (1) | AU2021261060A1 (cg-RX-API-DMAC10.html) |
| CA (1) | CA3174429A1 (cg-RX-API-DMAC10.html) |
| IL (1) | IL297363A (cg-RX-API-DMAC10.html) |
| WO (1) | WO2021212222A1 (cg-RX-API-DMAC10.html) |
Families Citing this family (1)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US12165313B2 (en) * | 2019-01-14 | 2024-12-10 | Ark Inc. | Deep learning architecture system for automatic fundus image reading and automatic fundus image reading method using deep learning architecture system |
Family Cites Families (8)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US7312320B2 (en) * | 2003-12-10 | 2007-12-25 | Novimmune Sa | Neutralizing antibodies and methods of use thereof |
| US7674884B2 (en) * | 2003-12-10 | 2010-03-09 | Novimmune S.A. | Neutralizing antibodies and methods of use thereof |
| SI2173381T1 (sl) * | 2007-05-14 | 2014-01-31 | Novimmune Sa | Fc receptor-vezavni polipeptidi z modificiranimi efektorskimi funkcijami |
| JP6289098B2 (ja) * | 2011-01-10 | 2018-03-07 | ノビミューン エスアー | 抗tlr4抗体およびその使用法 |
| HUE037613T2 (hu) * | 2012-03-29 | 2018-09-28 | Novimmune Sa | Anti-TLR4 antitestek és azok felhasználása |
| EP3060250A1 (en) * | 2013-10-22 | 2016-08-31 | NovImmune SA | Methods and compositions for diagnosis and treatment of disorders in patients with elevated levels of tlr4 ligands and other biomarkers |
| WO2017021552A1 (en) * | 2015-08-06 | 2017-02-09 | Novimmune Sa | Methods and compositions for identifying patient populations for diagnosis and treatment of tlr4-dependent disorders |
| EP3519049B1 (en) * | 2016-09-30 | 2025-12-03 | Janssen Biotech, Inc. | Safe and effective method of treating psoriasis with anti-il23 specific antibody |
-
2021
- 2021-04-20 WO PCT/CA2021/050544 patent/WO2021212222A1/en not_active Ceased
- 2021-04-20 CA CA3174429A patent/CA3174429A1/en active Pending
- 2021-04-20 CN CN202180043755.8A patent/CN115697410A/zh active Pending
- 2021-04-20 AU AU2021261060A patent/AU2021261060A1/en active Pending
- 2021-04-20 US US17/920,323 patent/US20230192881A1/en active Pending
- 2021-04-20 EP EP21791947.1A patent/EP4138912A4/en active Pending
- 2021-04-20 IL IL297363A patent/IL297363A/en unknown
- 2021-04-20 JP JP2023506362A patent/JP2023523096A/ja active Pending
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| JP2023515271A5 (cg-RX-API-DMAC10.html) | ||
| JP2020518599A5 (cg-RX-API-DMAC10.html) | ||
| JP2004534513A5 (cg-RX-API-DMAC10.html) | ||
| JP2022531205A5 (cg-RX-API-DMAC10.html) | ||
| JP2024518536A5 (cg-RX-API-DMAC10.html) | ||
| JP2022535523A5 (cg-RX-API-DMAC10.html) | ||
| JP2025511167A5 (cg-RX-API-DMAC10.html) | ||
| CN111163792A (zh) | 用于治疗病毒感染的肽 | |
| JP2025176030A (ja) | ウイルス起源の各感染症の治療のためのペプチド | |
| JP2024177399A (ja) | 呼吸器疾患の治療のための汎elr+cxcケモカイン抗体 | |
| US20240117058A1 (en) | Treatment of cytokine release syndrome with gm-csf antagonists | |
| EP4655001A1 (en) | Method for prevention or treatment of coronavirus infection | |
| US20230357418A1 (en) | Results of empacta: a randomized, double-blind, placebo-controlled, multicenter study to evaluate the efficacy and safety of tocilizumab in hospitalized patients with covid-19 pneumonia | |
| JP2023526853A5 (cg-RX-API-DMAC10.html) | ||
| EP4107186A1 (en) | Tocilizumab and remdesivir combination therapy for covid-19 pneumonia | |
| JP2022553703A5 (cg-RX-API-DMAC10.html) | ||
| KR20250148609A (ko) | 코로나바이러스 감염의 예방 또는 치료 방법 | |
| KR20250148604A (ko) | 코로나바이러스 감염의 예방 또는 치료 방법 | |
| KR20250148605A (ko) | 코로나바이러스 감염의 예방 또는 치료 방법 | |
| EP4655003A1 (en) | Method for prevention or treatment of coronavirus infection | |
| JP2023518815A (ja) | Il6アンタゴニストによるcovid-19肺炎を含む肺炎の治療方法 | |
| JP2023538369A5 (cg-RX-API-DMAC10.html) |